Form4.ai tracks every SEC insider trade in real time. See every TAK insider filing with a free account — no card.
See every TAK insider filing — free account, no card.
Free accountTAKEDA PHARMACEUTICAL CO LTD (TAK) has 19 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 19 sales totalling $13.1M. Most recent filing: Sept. 15, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 15, 2026 SEC filing | Duprey Lauren Rusckowski Chief Transformation Officer | Sold | $640,279 | — |
| Sep 3, 2026 SEC filing | Plump Andrew Stewart President, R&D | Sold | $2,148,372 | — |
| Aug 21, 2026 SEC filing | Plump Andrew Stewart President, R&D | Sold | $363,347 | — |
Create a free account to see all 19 TAK filings from the last 90 days. No card needed.
Create free accountWant TAK insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.